Lower severity of steatosis was found in S. spinosum-treated KK-Ay mice, accompanied with lower mRNA expression of CD36, a biomarker of atherogenesis and metabolic dysfunction as well as some others pro-inflammatory genes. The gene discussed is CD36; the disease is steatosis.